An Analysis of the IND Filing Process of Development Including Application to the FDA.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c27762 ) has announced the addition of Discovery To IND Filing to their offering Currently, post-discovery drug development is a stringent process in which molecules discovered and studied in cells now undergo animal testing Animal testing or animal research refers to the use of animals in experiments. It is estimated that 50 to 100 million vertebrate animals worldwide [4][5][6] before an IND application can be filed with the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. . The FDA is a governing body that imposes strict rules and regulations as to how the discovered molecules have to be developed before testing in humans. The FDA's guidelines ensure the safety of these molecules (based on the post-discovery testing) before they are tested in humans. The FDA provides clear-cut guidelines on how experimentation is done post discovery. Upon review of the data generated in the drug development process, the FDA approves or disapproves the testing of the candidate molecule for testing in human trials. Discovery to IND Filing analyzes the preclinical discovery and post-discovery drug development process leading to the filing of a successful IND application. Get answers to crucial questions such as: - What are the steps required for drug development required by FDA? - What IND enabling studies are required by the FDA? This publication provides an in depth review of the major steps as well as the modern techniques that are utilized in the discovery to IND filing process. This report gives the reader a detailed breakdown of the steps involved in the different stages of therapeutic drug discovery and development. It also provides detailed analysis of identification of small molecules using HTS HTS Heights HTS Harmonized Tariff System HTS High Throughput Screening (biomolecular assay screening) HTS High-Throughput Screening (Pharmaceutical Industry) HTS Harmonized Tariff Schedule and other strategies, as well as a detailed analysis of steps that are taken post discovery including animal testing, pK/pD analysis, toxicity testing and efficacy analysis. About the Author Dr. Anil Sehgal obtained his Ph.D. in Biomedical Sciences in 1994 from a Joint Program between Old Dominion University “ODU” redirects here. For other uses, see ODU (disambiguation). The university was recently named one of the best colleges in the Southeast by The Princeton Review. and Eastern Virginia Medical School Eastern Virginia Medical School, in Norfolk, Virginia is a public medical school. . He served as Assistant Member at the Pacific Northwest Cancer Foundation in Seattle before joining UCSF UCSF University of California at San Francisco . He initiated a molecular marker program in brain tumor Brain Tumor Definition A brain tumor is an abnormal growth of tissue in the brain. Unlike other tumors, brain tumors spread by local extension and rarely metastasize (spread) outside the brain. area at UCSF. He has published over 20 publications and has presented in numerous National and International Conferences. He also holds several patents in the area of markers and targets for cancer therapeutics. He recently served as Director of Molecular Biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller and Genomics at ChemGenex Therapeutics. He is currently working as a consultant for startup companies. For more information visit http://www.researchandmarkets.com/reports/c27762 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion